Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 468-474

  Falagas, Matthew E ^a   Snydman, David R ^a   Griffith, John ^a   Werner, Barbara G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SERODIAGNOSIS;

EID: 0029830083     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.468     Document Type: Article

References (17)

1. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989;124:1443-50.
2. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994;170:644-52.
3. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993;18: 185-95.
4. George MJ, Snydman DR, Werner BG, Dougherty N, Griffith J, CMVIG study group. Cytomegalovirus disease as a risk factor for fungal disease in orthotopic liver transplant recipients [abstract no 32]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992:116.
5. Chatterjee SN, Fiala M, Weiner J, Stewart JA, Stacey B, Warner N. Primary cytomegalovirus and opportunistic infections: incidence in renal transplant recipients. JAMA 1978;240:2446-9.
6. Rand KH, Pollard RB, Merigan TC. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 1978;298:951-3.
7. Gorensek MJ, Stewart RW, Keys TF, McHenry MC, Babiak T, Goormastic M. Symptomatic cytomegalovirus infection as a significant risk factor for major infections after cardiac transplantation. J Infect Dis 1988;158: 884-7.
8. Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995;59:851-9.
9. Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994;344:1737-8.
10. O'Grady JG, Alexander GJM, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bileduct syndrome after liver transplantation. Lancet 1988;2:302-5.
11. Colonna JO II, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988;123:360-4.
12. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67: 132-43.
13. Paya CV, Hermans PE, Washington JA II, et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64:555-64.
14. George DL, Arnow PM, Fox AS, et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991;13:387-96.
15. Saliba F, Ephraim R, Mathieu D, et al. Risk factors for bacterial infection after liver transplantation. Transplant Proc 1994;26:266.
16. Bubak ME, Porayko MK, Krom RAF, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology 1991;14:1063-5.
17. McClean K, Kneteman N, Taylor G. Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994;15:582-4.